Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury

Journal of Molecular and Cellular Cardiology

Volumn 90, Issue , 2016, Pages 21-29

  Kolpakov, Mikhail A ^a   Rafiq, Khadija ^b   Guo, Xinji ^a   Hooshdaran, Bahman ^a   Wang, Tao ^a   Vlasenko, Liudmila ^a,c   Bashkirova, Yulia V ^a   Zhang, Xiaoxiao ^a   Chen, Xiongwen ^a   Iftikhar, Sahar ^a   Libonati, Joseph R ^d   Kunapuli, Satya P ^a   Sabri, Abdelkarim ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c INSTITUTE OF MOLECULAR AND CELLULAR BIOLOGY   (Russian Federation)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Cardioprotection; Inflammation; Myocardial ischemia reperfusion; Thrombin receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; JANUS KINASE; PROTEIN TYROSINE KINASE; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; EGFR PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PEPTIDE; PROTEASE-ACTIVATED RECEPTOR 4; SMALL INTERFERING RNA; THROMBIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; EX VIVO STUDY; GENE INACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY; PRIMARY CELL CULTURE;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; MALE; MAP KINASE KINASE 4; MICE; MICE, KNOCKOUT; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PEPTIDES; PRIMARY CELL CULTURE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, THROMBIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; THROMBIN;

EID: 84961711563     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.030     Document Type: Article

References (37)

1. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N. Engl. J. Med. 2007, 357:1121-1135.
2. Piper H.M., Garcna-Dorado D., Ovize M. A fresh look at reperfusion injury. Cardiovasc. Res. 1998, 38:291-300.
3. Heutinck K., ten Berge I., Hack C., Hamann J., Rowshani A. Serine proteases of the human immune system in health and disease. Mol. Immunol. 2010, 47:1943-1955.
4. Steinberg S.F. The cardiovascular actions of protease-activated receptors. Mol. Pharmacol. 2005, 67:2-11.
5. Adams M.N., Ramachandran R., Yau M.-K., Suen J.Y., Fairlie D.P., Hollenberg M.D., et al. Structure, function and pathophysiology of protease activated receptors. Pharmacol. Ther. 2011, 130:248-282.
6. Coughlin S.R. How the protease thrombin talks to cells. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11023-11027.
7. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 2000, 407:258-264.
8. Sabri A., Short J., Guo J., Steinberg S.F. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ. Res. 2002, 91:532-539.
9. Kahn M.L., Zheng Y.-W., Huang W., Bigornia V., Zeng D., Moff S., et al. A dual thrombin receptor system for platelet activation. Nature 1998, 394:690-694.
10. Pawlinski R., Tencati M., Hampton C.R., Shishido T., Bullard T.A., Casey L.M., et al. Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation 2007, 116:2298-2306.
11. Cottrell G.S., Amadesi S., Grady E.F., Bunnett N.W. Trypsin IV, a novel agonist of protease-activated receptors 2 and 4. J. Biol. Chem. 2004, 279:13532-13539.
12. Oikonomopoulou K., Hansen K.K., Saifeddine M., Tea I., Blaber M., Blaber S.I., et al. Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 2006, 281:32095-32112.
13. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 2000, 275:6819-6823.
14. Hamilton J.R., Cornelissen I., Coughlin S.R. Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets. J. Thromb. Haemost. 2004, 2:1429-1435.
15. Sambrano G.R., Weiss E.J., Zheng Y.-W., Huang W., Coughlin S.R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001, 413:74-78.
16. Hollenberg M.D., Saifeddine M., Sandhu S., Houle S., Vergnolle N. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo. Br. J. Pharmacol. 2004, 143:443-454.
17. Vergnolle N., Derian C.K., D'Andrea M.R., Steinhoff M., Andrade-Gordon P. Characterization of thrombin-induced leukocyte rolling and adherence: a potential proinflammatory role for proteinase-activated receptor-4. J. Immunol. 2002, 169:1467-1473.
18. Sabri A., Guo J., Elouardighi H., Darrow A.L., Andrade-Gordon P., Steinberg S.F. Mechanisms of protease-activated receptor-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J. Biol. Chem. 2003, 278:11714-11720.
19. Strande J.L., Hsu A., Su J., Fu X., Gross G.J., Baker J.E. Inhibiting protease-activated receptor 4 limits myocardial ischemia/reperfusion injury in rat hearts by unmasking adenosine signaling. J. Pharmacol. Exp. Ther. 2008, 324:1045-1054.
20. Kukielka G.L., Smith C.W., Manning A.M., Youker K.A., Michael L.H., Entman M.L. Induction of interleukin-6 synthesis in the myocardium: potential role in postreperfusion inflammatory injury. Circulation 1995, 92:1866-1875.
21. Hwang M.-W., Matsumori A., Furukawa Y., Ono K., Okada M., Iwasaki A., et al. Neutralization of interleukin-1β in the acute phase of myocardial infarction promotes the progression of left ventricular remodeling. J. Am. Coll. Cardiol. 2001, 38:1546-1553.
22. Sabri A., Muske G., Zhang H., Pak E., Darrow A., Andrade-Gordon P., et al. Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ. Res. 2000, 86:1054-1061.
23. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., et al. Cloning and characterization of human protease-activated receptor-4. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:6642-6646.
24. Baines C.P., Molkentin J.D. Stress signaling pathways that modulate cardiac myocyte apoptosis. J. Mol. Cell. Cardiol. 2005, 38:47-62.
25. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat. Med. 2002, 8:35-40.
26. Zarbock A., Polanowska-Grabowska R.K., Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007, 21:99-111.
27. Asokananthan N., Graham P.T., Fink J., Knight D.A., Bakker A.J., McWilliam A.S., et al. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J. Immunol. 2002, 168:3577-3585.
28. Rossignol P., Bouton M.-C., Jandrot-Perrus M., Bryckaert M., Jacob M.-P., Bezeaud A., et al. A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp. Cell Res. 2004, 299:279-285.
29. Wu X., Zhang W., Li J.-Y., Chai B.-X., Peng J., Wang H., et al. Induction of apoptosis by thrombin in the cultured neurons of dorsal motor nucleus of the vagus. Neurogastroenterol. Motil. 2011, 23:279-e124.
30. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 2002, 366:381-416.
31. Sabri A., Wilson B.A., Steinberg S.F. Dual actions of the Galpha(q) agonist Pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ. Res. 2002, 90:850-857.
32. Eto M., Kozai T., Cosentino F., Joch H., Lüscher T.F. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 2002, 105:1756-1759.
33. Shao Z., Bhattacharya K., Hsich E., Park L., Walters B., Germann U., et al. c-Jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. Circ. Res. 2006, 98:111-118.
34. Kaiser R.A., Liang Q., Bueno O., Huang Y., Lackey T., Klevitsky R., et al. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. J. Biol. Chem. 2005, 280:32602-32608.
35. Rafiq K., Hanscom M., Valerie K., Steinberg S., Sabri A. Novel mode for neutrophil protease cathepsin G-mediated signaling: membrane shedding of epidermal growth factor is required for cardiomyocyte anoikis. Circ. Res. 2008, 102:32-41.
36. Strande J.L., Hsu A., Su J., Fu X., Gross G.J., Baker J.E. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Basic Res. Cardiol. 2007, 102:350-358.
37. Shapiro M.J., Weiss E.J., Faruqi T.R., Coughlin S.R. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J. Biol. Chem. 2000, 275:25216-25221.